Drosophila Decapentaplegic/DPP Antibody, R&D Systems™
Manufacturer: R&D Systems
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | MAB159-Each-of-1 | In Stock | ₹ 56,041.80 |
MAB159 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 56,041.80
GST (18%): ₹ 10,087.524
Total Price: ₹ 66,129.324
Antigen
Decapentaplegic/DPP
Classification
Monoclonal
Concentration
LYOPH
Dilution
Western Blot 1 ug/mL
Gene Accession No.
NP_722813.1
Immunogen
E. coli-derived recombinantDrosophilaDecapentaplegic/DPP Asp457-Arg588 (Gln473His, Pro474Ala) Accession # NP_722813.1
Quantity
500 μg
Primary or Secondary
Primary
Reconstitution
Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype
IgG2b
Applications
Western Blot
Clone
146609
Conjugate
Unconjugated
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Host Species
Mouse
Purification Method
Protein A or G purified from hybridoma culture supernatant
Regulatory Status
RUO
Test Specificity
DetectsDrosophilaDecapentaplegic/DPP in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant human (rh) TGF-alpha , rhTGF-beta 1, rhTGF-beta 1.2, rhTGF-beta 2, rhTGF-beta 3, rhLAP, recombinant porcine (rp) TGF-beta 1.2, rpTGF-beta 2, or recombinant amphibian TGF-beta 5 is observed.
Target Species
Drosophila
Form
Purified
Related Products
Description
- Decapentaplegic/DPP Monoclonal specifically detects Decapentaplegic/DPP in Drosophila samples
- It is validated for Western Blot.
Compare Similar Items
Show Difference
Antigen: Decapentaplegic/DPP
Classification: Monoclonal
Concentration: LYOPH
Dilution: Western Blot 1 ug/mL
Gene Accession No.: NP_722813.1
Immunogen: E. coli-derived recombinantDrosophilaDecapentaplegic/DPP Asp457-Arg588 (Gln473His, Pro474Ala) Accession # NP_722813.1
Quantity: 500 μg
Primary or Secondary: Primary
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype: IgG2b
Applications: Western Blot
Clone: 146609
Conjugate: Unconjugated
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Host Species: Mouse
Purification Method: Protein A or G purified from hybridoma culture supernatant
Regulatory Status: RUO
Test Specificity: DetectsDrosophilaDecapentaplegic/DPP in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant human (rh) TGF-alpha , rhTGF-beta 1, rhTGF-beta 1.2, rhTGF-beta 2, rhTGF-beta 3, rhLAP, recombinant porcine (rp) TGF-beta 1.2, rpTGF-beta 2, or recombinant amphibian TGF-beta 5 is observed.
Target Species: Drosophila
Form: Purified
Antigen: FGF-BP
Classification: Monoclonal
Concentration: LYOPH
Dilution: Western Blot 1 ug/mL
Gene Accession No.: Q14512
Immunogen: E. coli-derived recombinant human FGF-BP Val35-Cys234 Accession # Q14512
Quantity: 500 μg
Primary or Secondary: Primary
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype: IgG1
Applications: Western Blot
Clone: 196519
Conjugate: Unconjugated
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Host Species: Mouse
Purification Method: Protein A or G purified from hybridoma culture supernatant
Regulatory Status: RUO
Test Specificity: Detects human FGF-BP in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant rat FGF-BP is observed.
Target Species: Human
Form: Purified
Antigen: FGF-BP
Classification: Monoclonal
Concentration: LYOPH
Dilution: Western Blot 1 ug/mL
Gene Accession No.: Q14512
Immunogen: E. coli-derived recombinant human FGF-BP Val35-Cys234 Accession # Q14512
Quantity: 25 μg
Primary or Secondary: Primary
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype: IgG1
Applications: Western Blot
Clone: 196519
Conjugate: Unconjugated
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Host Species: Mouse
Purification Method: Protein A or G purified from hybridoma culture supernatant
Regulatory Status: RUO
Test Specificity: Detects human FGF-BP in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant rat FGF-BP is observed.
Target Species: Human
Form: Purified
